Gene therapy: Commenced a Phase I trial in 15 patients

Targeted Genetics Corp. Product: Gene therapy using HIV-specific T cells taken from HIV-positive patients and modified with HyTK Indication: Treat HIV Status: Commenced a Phase I trial in 15 patients ...